D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 150 Citations 89,422 505 World Ranking 28 National Ranking 20
Medicine D-index 157 Citations 99,674 616 World Ranking 309 National Ranking 198
Best Scientists D-index 178 Citations 122,922 923 World Ranking 465 National Ranking 312

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

2020 - Member of the National Academy of Sciences

2020 - Distinguished Fellows of the American Association of Immunologists (AAI)

2018 - Albany Medical Center Prize in Medicine and Biomedical Research

2015 - Paul Ehrlich and Ludwig Darmstaedter Prize

2014 - Fellow of the American Academy of Arts and Sciences

2014 - Karl Landsteiner Memorial Award, American Association of Blood Banks (AABB)

2014 - AAI-Steinman Award for Human Immunology Research, American Association of Immunologists

2012 - Member of the National Academy of Medicine (NAM)

2012 - Distinguished Service Award, Clinical Immunology Society

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Immune system

Carl H. June spends much of his time researching Immunology, Antigen, T cell, Chimeric antigen receptor and Immunotherapy. His studies in Immunology integrate themes in fields like Cytotoxic T cell, Cancer and Cell therapy. The study incorporates disciplines such as Antibody, B cell, Receptor, Chimeric Antigen Receptor T-Cell Therapy and T-cell receptor in addition to Antigen.

He works on T cell which deals in particular with CD28. The concepts of his Chimeric antigen receptor study are interwoven with issues in Cancer research and Leukemia. His work carried out in the field of Immunotherapy brings together such families of science as Acquired immune system and Tumor microenvironment.

His most cited work include:

  • Chimeric antigen receptor T cells for sustained remissions in leukemia. (2837 citations)
  • Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (2518 citations)
  • Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. (2270 citations)

What are the main themes of his work throughout his whole career to date?

Carl H. June focuses on Immunology, T cell, Chimeric antigen receptor, Cancer research and Antigen. His Immunology research integrates issues from Cytotoxic T cell and Internal medicine. His T cell research incorporates themes from Molecular biology, CD8 and Cell biology.

His Chimeric antigen receptor course of study focuses on CD19 and B cell. His Cancer research study combines topics in areas such as Car t cells and In vivo. His Antigen study combines topics from a wide range of disciplines, such as Receptor and Antibody.

He most often published in these fields:

  • Immunology (43.09%)
  • T cell (36.69%)
  • Chimeric antigen receptor (28.07%)

What were the highlights of his more recent work (between 2015-2021)?

  • Chimeric antigen receptor (28.07%)
  • Cancer research (23.54%)
  • T cell (36.69%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Chimeric antigen receptor, Cancer research, T cell, Immunology and Immunotherapy. His Chimeric antigen receptor research includes elements of Leukemia, Cell therapy and Antigen, CD19. In his study, T-cell receptor is strongly linked to Cancer immunotherapy, which falls under the umbrella field of Cancer research.

Carl H. June has researched T cell in several fields, including Ex vivo, CD8, Molecular biology, Cell biology and Cytotoxic T cell. His research integrates issues of Stem cell and Transplantation in his study of Immunology. His Immunotherapy study incorporates themes from Tumor microenvironment, Viral vector, Oncology and Lymphoma.

Between 2015 and 2021, his most popular works were:

  • Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia (1540 citations)
  • CAR T cell immunotherapy for human cancer (791 citations)
  • Cytokine release syndrome in severe COVID-19. (692 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Immune system

His main research concerns Chimeric antigen receptor, Immunotherapy, Cancer research, Antigen and T cell. He is conducting research in Immunology and Immune system as part of his Chimeric antigen receptor study. Carl H. June has included themes like Signal transduction, Toxicity and Transplantation in his Immunology study.

His Immunotherapy study combines topics from a wide range of disciplines, such as Antibody, Cell therapy and Oncology. The Antigen study combines topics in areas such as Receptor, Cytotoxic T cell, Chimeric Antigen Receptor T-Cell Therapy and Lymphoma. His work carried out in the field of T cell brings together such families of science as Oncolytic adenovirus, Oncolytic virus and Viral vector.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Chimeric antigen receptor T cells for sustained remissions in leukemia.

Shannon L. Maude;Noelle Frey;Pamela A. Shaw;Richard Aplenc.
The New England Journal of Medicine (2014)

3844 Citations

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

David L. Porter;Bruce L. Levine;Michael Kalos;Adam Bagg.
The New England Journal of Medicine (2011)

3412 Citations

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Stephan A. Grupp;Michael Kalos;David Barrett;Richard Aplenc.
The New England Journal of Medicine (2013)

3032 Citations

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

Michael Kalos;Bruce L. Levine;David L. Porter;Sharyn Katz.
Science Translational Medicine (2011)

2438 Citations

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

S. L. Maude;Theodore W Laetsch;J. Buechner;S. Rives.
The New England Journal of Medicine (2018)

1959 Citations

The B7 and CD28 receptor families

Carl H. June;Jeffrey A. Bluestone;Lee M. Nadler;Craig B. Thompson.
Immunology Today (1994)

1670 Citations

CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL

Lawrence H. Boise;Andy J. Minn;Patricia J. Noel;Carl H. June.
Immunity (1995)

1542 Citations

Regulatory CD4+CD25+ T Cells in Tumors from Patients with Early-Stage Non-Small Cell Lung Cancer and Late-Stage Ovarian Cancer

Edward Y. Woo;Christina S. Chu;Theresa J. Goletz;Katia Schlienger.
Cancer Research (2001)

1495 Citations

Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV

Pablo Tebas;David Stein;Winson W. Tang;Ian Frank.
The New England Journal of Medicine (2014)

1358 Citations

A human memory T cell subset with stem cell-like properties

Luca Gattinoni;Enrico Lugli;Yun Ji;Zoltan Pos.
Nature Medicine (2011)

1252 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Carl H. June

Stanley R. Riddell

Stanley R. Riddell

Fred Hutchinson Cancer Research Center

Publications: 157

Bruce R. Blazar

Bruce R. Blazar

University of Minnesota

Publications: 155

Gianpietro Dotti

Gianpietro Dotti

University of North Carolina at Chapel Hill

Publications: 150

Malcolm K. Brenner

Malcolm K. Brenner

Baylor College of Medicine

Publications: 123

Laurence J.N. Cooper

Laurence J.N. Cooper

The University of Texas MD Anderson Cancer Center

Publications: 116

Renier J. Brentjens

Renier J. Brentjens

Memorial Sloan Kettering Cancer Center

Publications: 116

Jeffrey A. Bluestone

Jeffrey A. Bluestone

University of California, San Francisco

Publications: 116

Arlene H. Sharpe

Arlene H. Sharpe

Harvard University

Publications: 114

Michel Sadelain

Michel Sadelain

Memorial Sloan Kettering Cancer Center

Publications: 110

Nicholas P. Restifo

Nicholas P. Restifo

National Institutes of Health

Publications: 109

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 106

George Coukos

George Coukos

University of Lausanne

Publications: 106

Gordon J. Freeman

Gordon J. Freeman

Harvard University

Publications: 103

Cliona M. Rooney

Cliona M. Rooney

Baylor College of Medicine

Publications: 99

Helen E. Heslop

Helen E. Heslop

Baylor College of Medicine

Publications: 95

Crystal L. Mackall

Crystal L. Mackall

Stanford University

Publications: 95

Trending Scientists

Nicholas C. Wormald

Nicholas C. Wormald

Monash University

Dusan M. Stipanovic

Dusan M. Stipanovic

University of Illinois at Urbana-Champaign

Bernard Rousseau

Bernard Rousseau

University of Paris-Sud

Etienne Snoeck

Etienne Snoeck

Centre national de la recherche scientifique, CNRS

Dong Hyuk Shin

Dong Hyuk Shin

Hanyang University

George F. Turner

George F. Turner

Bangor University

Stéphane Declerck

Stéphane Declerck

Université Catholique de Louvain

Trevor Williams

Trevor Williams

Texas A&M University

Peter S. Holt

Peter S. Holt

Agricultural Research Service

Matthew I. Leybourne

Matthew I. Leybourne

Queen's University

Henk Aarts

Henk Aarts

Utrecht University

Michelle Duffy

Michelle Duffy

University of Newcastle Australia

William A. Mason

William A. Mason

University of California, Davis

Andrew Simmons

Andrew Simmons

King's College London

Lisa J Harnack

Lisa J Harnack

University of Minnesota

Dominique Boisson

Dominique Boisson

University of Lyon System

Something went wrong. Please try again later.